Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2025 Earnings Call Transcript February 25, 2026
Ionis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.41358 EPS, expectations were $-1.23667.
Operator: Good morning, and welcome to Ionis’ Fourth Quarter and Full Year 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off...
